In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
about
Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical ApplicationsDefining the role of laminin-332 in carcinoma.Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice.The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiationHost immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.In vivo assessment of gene delivery to keratinocytes by lentiviral vectorsTissue-engineered skin substitutes.DNMT1 maintains progenitor function in self-renewing somatic tissue.Cutaneous gene transfer for skin and systemic diseases.Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity.c-Jun promotes whereas JunB inhibits epidermal neoplasiaThe molecular genetics of the genodermatoses: progress to date and future directions.Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.Gene therapy of epidermolysis bullosa.CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth controlGab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation.Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.Modelling cancer in human skin tissue.Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa.Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.Module map of stem cell genes guides creation of epithelial cancer stem cellsA skin-depth analysis of integrins: role of the integrin network in health and disease.Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK.Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue.Nucleus pulposus cell-matrix interactions with laminins.Dermatology: Where are We Coming from and Where are We Going to?Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.Durable and stratum-specific gene expression in epidermis.NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis.Stable nonviral genetic correction of inherited human skin disease.Microprocessor-dependent processing of splice site overlapping microRNA exons does not result in changes in alternative splicing
P2860
Q26778010-807BA0C6-68AE-4ADD-AF21-0B760982779AQ33875126-AC417253-68FC-438C-B283-F14E1FEC4FD3Q34069632-42879413-4538-4235-8816-B5DDBDB826E6Q34230973-CA49857B-39DA-4E00-9F18-968EF49CE225Q34293796-D79B1F0A-E74C-4297-AB92-596A68AB3EE8Q34328596-482F5A08-8F59-49BD-9FBC-3802BF45E80CQ34482049-35B81F08-DD04-4B02-AFE5-339455E97AD6Q34632106-CB031398-DDBF-458E-B059-1A65B6E2F04CQ34696240-DAC20174-AB1D-465A-A53C-9D648DC220ECQ34928301-24AB77FF-FB22-4216-B860-71F582BD73D0Q35024869-25E4861E-2730-4112-B938-A902DEF994E1Q35048159-D0DF8745-BBE6-4B30-BB30-27CAEA497356Q35056805-C09E44DF-5F43-435B-9A29-20AED1130EC4Q35873767-9F22B770-CEA9-45A7-9321-5D186FEF7F16Q36321393-E9506C84-5E4D-46EB-8D9D-31982507F308Q36324505-DA19666F-4964-4CCC-A41C-AA9564E82BCEQ36326838-1B6698E9-9825-4C87-9C0C-4854C321C2AFQ36422870-78BBB076-0756-4F7A-8813-8072F781A07DQ36425931-B4DB38B5-6B6C-4BA2-8A43-B88B104FD2C2Q36445811-BAAECBBD-2379-4BE0-88BC-D77B0DE7B12BQ36454741-A0E733DB-55E7-48EA-BF07-B5F44A9AA82AQ37067205-160D1B2B-40A7-4C17-90A3-065C324F8D99Q38160890-09802CD3-3EB9-4725-9D04-8E1946613238Q38692453-5D424605-7485-4F33-926F-4B67D783F417Q39561583-99059703-DC57-4A4A-B8FA-F6E8889CD3BCQ39741008-B3EB929D-76C2-418A-844A-ABE1B07477FFQ40057903-8259C52D-6219-429D-94E1-BF0A1ABDEF21Q40431585-1A7B4F7E-E40F-436C-8ACB-57098470666FQ41956259-649E4A1D-B56E-4DA6-9D63-906A9506B52AQ41957108-23E2543E-245C-4A5B-9132-D10A331856FBQ42014807-2A3A656B-D7BD-4302-BB2D-E178A057745CQ42175704-E93F96EE-D934-45F9-9D23-1DEA2AC48F73Q45862956-2B75CA5B-E861-4626-95C4-43ECE22D061FQ45889289-088A90ED-AF35-4E2A-B59F-B5DACACEFFA5Q45982548-52844AFD-04F1-4E6A-90EA-79C8CA27B3C3Q46492957-12BFE8C6-C5FA-47B1-8090-6D45E5F95A96Q46930709-5EF0787D-CCF6-4085-A947-59E26461AA29Q58778010-6A116F13-A3F8-4ADF-8B1C-A46D1500AFC3
P2860
In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@ast
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@en
type
label
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@ast
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@en
prefLabel
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@ast
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@en
P2093
P2860
P356
P1476
In vivo restoration of laminin ...... ctional epidermolysis bullosa.
@en
P2093
P2860
P304
P356
10.1073/PNAS.091484998
P407
P577
2001-04-10T00:00:00Z